nitude of present challenges exceeds that of past successes. In an era in which the secrets of the genetic code have been unraveled and fundamental processes of life are being newly understood, people everywhere still face a future marred by the stark realities of global climate change, the proliferation of weapons of mass destruction, and the spread of infectious disease.
And while the beneficial impacts of technological change have been dramatic, they have not been broadly shared. The majority of people in the world continue to live in persistently poor places, where the local environment is deteriorating and sickness is a daily fact of life.
Existing institutions and incentive structures may or may not be adequate to address these challenges. If the past is any guide, continued progress in addressing public challenges will require continued innovations-the efforts of individuals, groups, and communities who creatively employ new organizational forms, and in many cases new technology, to effect discontinuous change.
This journal is about such innovations and the changes that they bring about. It is less about what needs to be done, and more about what people are doing. Our purpose is to capitalize on the fundamental nature of innovations. Innovations can be copied and possibly scaled up. Innovations open up new possibilities and create the ground for yet more innovations. By drawing attention to innovations in the public interest, we intend to encourage critical thinking about them, and to spur their proliferation.
WHY INNOVATIONS?
Academic journals addressing public challenges typically are structured to address the general characteristics of problems rather than particulars of solutions. The problems in turn are binned by academic field of inquiry: for example, environment, development, health, and energy. However, as illustrated by the smallpox eradication effort, solutions often draw from multiple disciplines and modes of expertise. The conventional approach is successful in motivating communities of scholars to advance the frontiers of understanding within disciplinary boundaries-a key component of long-term advances in the social as well as the natural sciences. The system is less successful in providing guidance to those seeking near-term options for action leading to lasting solutions. Important insights with potentially broad application are often lost simply for lack of a common space where they can be found. By focusing on the particulars of practice, Innovations is intended to complement existing journals, providing a common space that cuts across academic disciplines, bridges theory and practice, and links human action with global impact.
This journal emphasizes the reciprocal interaction between technology and society. We are particularly interested in the actions of innovators who employ technology to change relationships and thus transform governance. 5 Here, "governance" refers to the institutions, processes, and traditions that determine how power is exercised, how citizens are given a voice, and how decisions are made on issues of public concern. "Technology" refers to things and processes derived from science and put to practical use. We consider the inspiration and impacts of innovations across multiple scales of analysis, both spatially (local, regional, and global) and temporally (short-term, medium-term, and long-term).
Why this focus? In the past century, technology has fundamentally changed the human experience. It shapes, and is shaped by, our institutions. Today, community, political, and business leaders are challenged to make critical decisions about technology. These decisions transcend state boundaries and have impacts over multiple time scales. They affect both our manmade and natural environments. Understanding their impacts and implications and broadening that understanding can influence the kind of human society we are able to build and the kind of natural environment we are able to protect.
ORGANIZATION OF THE JOURNAL
Each issue of Innovations will consist of four sections.
The first section will be an invited essay on the topic of innovations, focused on the interaction of technology and governance in a global context. In this essay, an authoritative figure will think through a policy issue-interpreting a long-term trend, identifying an emergent pattern, and/or assessing the accuracy of conventional wisdom.
The second section will consist of analyses of innovations in practice. These case narratives will be authored either by, or in collaboration with, the innovators themselves. Each will include discussion of motivations, challenges, strategies, outcomes, and unintended consequences. Each case narrative will be followed by commentary from an academic discussant. The discussant will highlight the aspects of the innovation that are analytically most interesting, have the most significant implications for policy, or best illustrate reciprocal relationships between technology and governance.
The third section will consist of accessible, policy-relevant research articles subjected to a process of peer commentary and/or review. We are particularly interested in publishing research that links practice and policy-micro and macro scales of analysis. The development of meaningful indicators of the impact of innovations will be an area of editorial emphasis.
The fourth section will consist of perspectives on policy. This section will publish analyses of innovations by large-scale public actors-national governments and transnational organizations. These analyses will consider the success and failure of policy informed by both empirical evidence and the experience of policy innovators. The development of improved modes of governance to facilitate and support innovations will be an area of editorial focus.
As the journal develops, we will use published content as the starting point for ongoing conversations among readers and authors. We will publish reader feedback and will host forums on topics addressed, engaging both practitioner and scholarly communities. This process is central to our undertaking. As editors of the journal, we do not view particular innovations presented as definitive or exclusive of others. Rather, it is through the exchange of ideas concerning the innovations that we hope better solutions will arise.
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A DEDICATION 6 The contributions to this inaugural issue establish the novelty, breadth, and analytic rigor of the material that we will publish in Innovations. As the biographies that accompany each article indicate, the authors are an exceptional group. We are grateful to all of them for their efforts in bringing this inaugural issue of Innovations to fruition.
Among them is one who we would like to acknowledge in particular. Jean Lanjouw was the first person we invited to author a contribution to Innovations. We sought her participation because we admired the singular manner in which she was able to maintain the highest technical standards in her scholarship at the same time that she demonstrated a deep and unwavering commitment to addressing issues of profound societal importance.
Lanjouw made important contributions in a variety of areas. Her series of studies on patent litigation and on the value of patents were widely-read and influential. Lanjouw also made significant contributions in economic development. She studied the role of land titles in urban squatter communities in Guayaquil, Ecuador, and emphasized their interaction with informal property rights. Her development of statistical tools that combined census and detailed survey data so as to view poverty and inequality at the village or neighborhood level, received much attention from academics and development practitioners. But her most influential work focused on empirically understanding the relationship between policies regarding intellectual property rights and economic development.
Debates about intellectual property rights are almost always heated. This is particularly true with regard to policies that relate to the impact of patents on access to critical medicines in the developing world. Yet there has been relatively little empirical research into patent policy and its implications. Lanjouw threw herself into this arena and came up with original and daring policy prescriptions.
The article of Lanjouw's that appears in our inaugural issue was first published as a Brookings working paper in 2001. Shortly before its release, the Wall Street Journal reported that "Yale University economist Jenny Lanjouw's plan-in which pharmaceutical companies would surrender patent rights for any new AIDS drugs in poor countries but enforce them in rich ones-is creating a stir at the World Bank and United Nations agencies. Executives at Merck & Co., the drug giant, are reviewing it, and the Treasury Department held a seminar on it last week… While the proposal… is far from being implemented, it is attracting attention from policy makers eager to find a way to address the AIDS epidemic, particularly in subSaharan Africa." 7 For four years, Lanjouw devoted substantial time to meeting with government officials and business leaders in settings as varied as corporate board rooms, the National Institutes of Health, and the World Economic Forum. Yet despite initial interest (and tireless engagement by Lanjouw), there was little movement. In June 2005, four years after the publication of Lanjouw's Brookings paper, the Washington Post's Sebastian Mallaby sought to redirect attention to Lanjouw's proposal. "There's an appetite to spend taxpayers' money on buying existing vaccines and on a 'pull mechanism' for new ones. But there's a third challenge in this medical battlefield: How to make drugs that have been invented for rich countries available in the poor world… Jean Lanjouw advanced a solution to [this] problem [in 2001 ]. The idea would cost nothing: It merely involves drug companies giving up patent protection for heart pills and sim-ilar medicines in the poor world. Since poor countries buy almost none of these medicines anyway, giving up patent rights in those markets doesn't hurt the drug firms. But it would mean that cheap generic versions of these medicines could be distributed to poor consumers." 8 Lanjouw's intention was to update the paper printed here, describing her experience in seeking to understand and influence the public policy process on the vital topic of pharmaceutical availability in developing countries. She did not have the opportunity to do so. She died on November 1, 2005, at the age of 43, three months after learning she was ill.
We dedicate this inaugural issue of Innovations to her memory.
